Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2014

01-12-2014 | Epidemiology

Association between persistence with mammography screening and stage at diagnosis among elderly women diagnosed with breast cancer

Authors: Ami Vyas, Suresh Madhavan, Usha Sambamoorthi

Published in: Breast Cancer Research and Treatment | Issue 3/2014

Login to get access

Abstract

Previous studies on the association between mammography screening and stage at breast cancer (BC) diagnosis have limitations because they did not analyze persistence with mammography screening and did not distinguish screening from diagnostic mammograms. The objective of this study is to determine the association between persistence with mammography screening and stage at BC diagnosis among elderly women. A retrospective observational study of 39,006 women age ≥70 diagnosed with incident BC from 2005 to 2009 from the Surveillance, Epidemiology, and End Results (SEER)-Medicare dataset was conducted. A validated algorithm with high sensitivity and specificity was used to distinguish between screening and diagnostic mammograms. Persistence with mammography screening was measured as having at least three screening mammograms in five years before BC diagnosis. Multinomial logistic regressions were performed to analyze the association between persistence with mammography screening and stage at diagnosis, in a multivariate framework. Overall, 46 % of elderly women were persistent with mammography screening, 26 % were not persistent, and 28 % did not have any screening mammogram in five years before BC diagnosis. As compared to women who were not persistent with mammography screening, women who were persistent with mammography screening were significantly more likely to be diagnosed at earlier stages of BC. The adjusted odds ratios were 3.28, 2.37, and 1.60 for in situ, local, and regional stages, respectively. A lower proportion of elderly women was persistent with mammography and it was highly associated with earlier stages of BC diagnosis. Interventions designed to promote persistent mammography screening among elderly women are warranted.
Literature
2.
go back to reference Hillner BE, Penberthy L, Desch CE, McDonald MK, Smith TJ, Retchin SM (1996) Variation in staging and treatment of local and regional breast cancer in the elderly. Breast Cancer Res Treat 40(1):75–86PubMedCrossRef Hillner BE, Penberthy L, Desch CE, McDonald MK, Smith TJ, Retchin SM (1996) Variation in staging and treatment of local and regional breast cancer in the elderly. Breast Cancer Res Treat 40(1):75–86PubMedCrossRef
4.
go back to reference Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE (2002) Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 359(9310):909–919PubMedCrossRef Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE (2002) Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 359(9310):909–919PubMedCrossRef
5.
go back to reference Smith-Bindman R, Kerlikowske K, Gebretsadik T, Newman J (2000) Is screening mammography effective in elderly women? Am J Med 108(2):112–119PubMedCrossRef Smith-Bindman R, Kerlikowske K, Gebretsadik T, Newman J (2000) Is screening mammography effective in elderly women? Am J Med 108(2):112–119PubMedCrossRef
6.
go back to reference Tabar L, Dean PB (2003) Mammography and breast cancer: the new era. Int J Gynaecol Obstet 82(3):319–326PubMedCrossRef Tabar L, Dean PB (2003) Mammography and breast cancer: the new era. Int J Gynaecol Obstet 82(3):319–326PubMedCrossRef
7.
go back to reference Hellquist BN, Duffy SW, Abdsaleh S, Bjorneld L, Bordas P, Tabar L et al (2011) Effectiveness of population-based service screening with mammography for women ages 40–49 years: evaluation of the Swedish mammography screening in young women (SCRY) cohort. Cancer 117(4):714–722PubMedCrossRef Hellquist BN, Duffy SW, Abdsaleh S, Bjorneld L, Bordas P, Tabar L et al (2011) Effectiveness of population-based service screening with mammography for women ages 40–49 years: evaluation of the Swedish mammography screening in young women (SCRY) cohort. Cancer 117(4):714–722PubMedCrossRef
8.
go back to reference Walter LC, Covinsky KE (2001) Cancer screening in elderly patients: a framework for individualized decision making. JAMA 285(21):2750–2756PubMedCrossRef Walter LC, Covinsky KE (2001) Cancer screening in elderly patients: a framework for individualized decision making. JAMA 285(21):2750–2756PubMedCrossRef
9.
go back to reference Caplan LS, Haynes SG (1996) Breast cancer screening in older women. Public Health Rev 24(2):193–204PubMed Caplan LS, Haynes SG (1996) Breast cancer screening in older women. Public Health Rev 24(2):193–204PubMed
10.
go back to reference Use of mammography services by women aged ≥65 years enrolled in Medicare-united states, 1991–1993 (1995) MMWR Morb Mortal Wkly Report; Report No. 44;777–781 Use of mammography services by women aged ≥65 years enrolled in Medicare-united states, 1991–1993 (1995) MMWR Morb Mortal Wkly Report; Report No. 44;777–781
12.
go back to reference US Preventive Services Task Force (2009) Screening for breast cancer: US preventive services task force recommendation statement. Ann Intern Med 151(10):716–726, W-236 US Preventive Services Task Force (2009) Screening for breast cancer: US preventive services task force recommendation statement. Ann Intern Med 151(10):716–726, W-236
13.
go back to reference Smith RA, Manassaram-Baptiste D, Brooks D, Cokkinides V, Doroshenk M, Saslow D et al (2014) Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 64(1):30–51PubMedCrossRef Smith RA, Manassaram-Baptiste D, Brooks D, Cokkinides V, Doroshenk M, Saslow D et al (2014) Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 64(1):30–51PubMedCrossRef
14.
go back to reference Day NE (1989) Quantitative approaches to the evaluation of screening programs. World J Surg 13(1):3–8PubMedCrossRef Day NE (1989) Quantitative approaches to the evaluation of screening programs. World J Surg 13(1):3–8PubMedCrossRef
15.
go back to reference Sant M, Allemani C, Capocaccia R, Hakulinen T, Aareleid T, Coebergh JW et al (2003) Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 106(3):416–422PubMedCrossRef Sant M, Allemani C, Capocaccia R, Hakulinen T, Aareleid T, Coebergh JW et al (2003) Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 106(3):416–422PubMedCrossRef
16.
go back to reference Randolph WM, Goodwin JS, Mahnken JD, Freeman JL (2002) Regular mammography use is associated with elimination of age-related disparities in size and stage of breast cancer at diagnosis. Ann Intern Med 137(10):783–790PubMedCrossRef Randolph WM, Goodwin JS, Mahnken JD, Freeman JL (2002) Regular mammography use is associated with elimination of age-related disparities in size and stage of breast cancer at diagnosis. Ann Intern Med 137(10):783–790PubMedCrossRef
17.
go back to reference McCarthy EP, Burns RB, Freund KM, Ash AS, Shwartz M, Marwill SL et al (2000) Mammography use, breast cancer stage at diagnosis, and survival among older women. J Am Geriatr Soc 48(10):1226–1233PubMed McCarthy EP, Burns RB, Freund KM, Ash AS, Shwartz M, Marwill SL et al (2000) Mammography use, breast cancer stage at diagnosis, and survival among older women. J Am Geriatr Soc 48(10):1226–1233PubMed
18.
go back to reference Badgwell BD, Giordano SH, Duan ZZ, Fang S, Bedrosian I, Kuerer HM et al (2008) Mammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol 26(15):2482–2488PubMedCrossRef Badgwell BD, Giordano SH, Duan ZZ, Fang S, Bedrosian I, Kuerer HM et al (2008) Mammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol 26(15):2482–2488PubMedCrossRef
19.
go back to reference Galit W, Green MS, Lital KB (2007) Routine screening mammography in women older than 74 years: a review of the available data. Maturitas 57(2):109–119PubMedCrossRef Galit W, Green MS, Lital KB (2007) Routine screening mammography in women older than 74 years: a review of the available data. Maturitas 57(2):109–119PubMedCrossRef
20.
go back to reference Freeman JL, Klabunde CN, Schussler N, Warren JL, Virnig BA, Cooper GS (2002) Measuring breast, colorectal, and prostate cancer screening with Medicare claims data. Med Care 40(8 Suppl):IV, 36–42 Freeman JL, Klabunde CN, Schussler N, Warren JL, Virnig BA, Cooper GS (2002) Measuring breast, colorectal, and prostate cancer screening with Medicare claims data. Med Care 40(8 Suppl):IV, 36–42
21.
go back to reference Fenton JJ, Zhu W, Balch S, Smith-Bindman R, Fishman P, Hubbard RA (2014) Distinguishing screening from diagnostic mammograms using Medicare claims data. Med Care 52(7):e44–e51PubMedCrossRef Fenton JJ, Zhu W, Balch S, Smith-Bindman R, Fishman P, Hubbard RA (2014) Distinguishing screening from diagnostic mammograms using Medicare claims data. Med Care 52(7):e44–e51PubMedCrossRef
22.
go back to reference Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF (2002) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40(8 Suppl):IV,3–18 Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF (2002) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40(8 Suppl):IV,3–18
23.
go back to reference Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (2001) SEER summary staging manual-2000: Codes and coding instructions, National Cancer Institute, NIH Pub. No. 01-4969, Bethasda Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (2001) SEER summary staging manual-2000: Codes and coding instructions, National Cancer Institute, NIH Pub. No. 01-4969, Bethasda
24.
go back to reference Randolph WM, Mahnken JD, Goodwin JS, Freeman JL (2002) Using medicare data to estimate the prevalence of breast cancer screening in older women: comparison of different methods to identify screening mammograms. Health Serv Res 37(6):1643–1657PubMedCentralPubMedCrossRef Randolph WM, Mahnken JD, Goodwin JS, Freeman JL (2002) Using medicare data to estimate the prevalence of breast cancer screening in older women: comparison of different methods to identify screening mammograms. Health Serv Res 37(6):1643–1657PubMedCentralPubMedCrossRef
25.
go back to reference Braithwaite D, Zhu W, Hubbard RA, O’Meara ES, Miglioretti DL, Geller B et al (2013) Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? J Natl Cancer Inst 105(5):334–341PubMedCentralPubMedCrossRef Braithwaite D, Zhu W, Hubbard RA, O’Meara ES, Miglioretti DL, Geller B et al (2013) Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? J Natl Cancer Inst 105(5):334–341PubMedCentralPubMedCrossRef
26.
go back to reference Andersen RM (1995) Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav 36(1):1–10PubMedCrossRef Andersen RM (1995) Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav 36(1):1–10PubMedCrossRef
27.
go back to reference Andersen R, Newman JF (1973) Societal and individual determinants of medical care utilization in the United States. Milbank Mem Fund Q Health Soc 51(1):95–124PubMedCrossRef Andersen R, Newman JF (1973) Societal and individual determinants of medical care utilization in the United States. Milbank Mem Fund Q Health Soc 51(1):95–124PubMedCrossRef
28.
go back to reference Klabunde CN, Potosky AL, Legler JM, Warren JL (2000) Development of a comorbidity index using physician claims data. J Clin Epidemiol 53(12):1258–1267PubMedCrossRef Klabunde CN, Potosky AL, Legler JM, Warren JL (2000) Development of a comorbidity index using physician claims data. J Clin Epidemiol 53(12):1258–1267PubMedCrossRef
29.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383PubMedCrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383PubMedCrossRef
31.
go back to reference Yu X, McBean AM, Virnig BA (2007) Physician visits, patient comorbidities, and mammography use among elderly colorectal cancer survivors. J Cancer Surviv 1(4):275–282PubMedCrossRef Yu X, McBean AM, Virnig BA (2007) Physician visits, patient comorbidities, and mammography use among elderly colorectal cancer survivors. J Cancer Surviv 1(4):275–282PubMedCrossRef
32.
go back to reference McCarthy EP, Burns RB, Coughlin SS, Freund KM, Rice J, Marwill SL et al (1998) Mammography use helps to explain differences in breast cancer stage at diagnosis between older black and white women. Ann Intern Med 128(9):729–736PubMedCrossRef McCarthy EP, Burns RB, Coughlin SS, Freund KM, Rice J, Marwill SL et al (1998) Mammography use helps to explain differences in breast cancer stage at diagnosis between older black and white women. Ann Intern Med 128(9):729–736PubMedCrossRef
33.
go back to reference Li CI, Malone KE, Daling JR (2003) Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 163(1):49–56PubMedCrossRef Li CI, Malone KE, Daling JR (2003) Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 163(1):49–56PubMedCrossRef
34.
35.
go back to reference Smedley B, Stith A, Nelson A (2002) Unequal treatment-confronting racial and ethnic disparities in health care. Institute of Medicine, National Academy Press, Washington, DC Smedley B, Stith A, Nelson A (2002) Unequal treatment-confronting racial and ethnic disparities in health care. Institute of Medicine, National Academy Press, Washington, DC
36.
go back to reference McDougall JA, Li CI (2010) Trends in distant-stage breast, colorectal, and prostate cancer incidence rates from 1992 to 2004: potential influences of screening and hormonal factors. Horm Cancer 1(1):55–62PubMedCrossRef McDougall JA, Li CI (2010) Trends in distant-stage breast, colorectal, and prostate cancer incidence rates from 1992 to 2004: potential influences of screening and hormonal factors. Horm Cancer 1(1):55–62PubMedCrossRef
37.
go back to reference Krieger N (1992) Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health 82(5):703–710PubMedCentralPubMedCrossRef Krieger N (1992) Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health 82(5):703–710PubMedCentralPubMedCrossRef
Metadata
Title
Association between persistence with mammography screening and stage at diagnosis among elderly women diagnosed with breast cancer
Authors
Ami Vyas
Suresh Madhavan
Usha Sambamoorthi
Publication date
01-12-2014
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2014
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-014-3204-3

Other articles of this Issue 3/2014

Breast Cancer Research and Treatment 3/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine